Org.nr 923 831 762 2024 → 2025 Year-over-year analysis

ADJUTEC PHARMA AS: årsregnskap 2025 vs 2024

Stronger earnings, fresh owner capital

approved 2026-05-18; registry 2026-07-09; journal 2026 559231

Summary

What changed

Comparing Årsregnskap 2025 with 2024 for ADJUTEC PHARMA AS. Net result -1.46m NOK → -1.12m NOK. Equity 33.34m NOK → 47.22m NOK.

On the constructive side: operating result improved; net result improved; equity strengthened.

Also worth watching: cogs fell. All figures are taken from the published annual accounts for ADJUTEC PHARMA AS.

At a glance

Revenue

7 333 NOK n/m

—

Operating result

-2.10m NOK -1.53m NOK

+27.1%

Net result

-1.46m NOK -1.12m NOK

+22.9%

Equity

33.34m NOK 47.22m NOK

+41.6%

Cash

6.54m NOK 16.29m NOK

+149.1%

Total assets

43.42m NOK 66.37m NOK

+52.9%

↑
Operating result improved

Operating result -2.10m NOK → -1.53m NOK. Calculated
↑
Net result improved

Net result -1.46m NOK → -1.12m NOK. Calculated
↑
Equity strengthened

Book equity 33.34m NOK → 47.22m NOK (equity ratio 76.8% → 71.1%). Calculated
↑
Cash rose

Bank deposits 6.54m NOK → 16.29m NOK (+149.1% YoY). Calculated
↑
Current ratio back above 1×

Current ratio -8.75× → 41.34×. Calculated

·
COGS fell

COGS / varekostnad -22.9k NOK → -14.28m NOK (-62274.8% YoY). Calculated